Extrasynaptic GABAA Receptors
GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAA and GABAB receptors. Recently, a novel form of GABAA receptor-mediated inhibition, termed “tonic” inhibition, has been described. Whereas synaptic GABAA receptors underlie classical “phasic” GABAA receptor-mediated inhib...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2014.
|
Σειρά: | The Receptors ;
27 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- A brief introduction to extrasynaptic GABAA receptors and ‘tonic’ GABAA receptor mediated inhibition in physiology and disease
- Extrasynaptic GABAA receptors: subunit composition, distribution, and regulation
- Biophysical properties of recombinant 2- AND δ- subunit containing GABAA receptors
- The pharmacology of extrasynaptic GABAA receptors
- Neurosteroids and extrasynaptic GABAA receptors
- Sources of GABA that activate extrasynaptic GABAA receptors
- Modulation of Extrasynaptic GABAA Receptors by G-protein-coupled Receptors
- Extrasynaptic GABAA receptors and tonic inhibition in spinal cord
- The role of peri-synaptic GABA receptors after stroke
- The role of extrasynaptic GABAA receptors in focal epilepsy
- Gain-of-Function of Thalamic Extrasynaptic GABA-A Receptors in Typical Absence Seizures
- GABAergic control of the hypothalamic-pituitary-adrenal (HPA) axis: role of extrasynaptic GABAA receptors
- Tonic GABAA receptor mediated inhibition in Fragile-X Syndrome: A cause of dysfunction or a pathway for a cure?